Defining and Distinguishing Treatment Abandonment in Patients with Cancer

Meaghann S. Weaver, Scott Howard, Catherine G. Lam

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Cancer management requires accurate identification of the causes of treatment failure followed by cause-specific interventions. One cause of treatment failure that has received too little attention is abandonment of treatment. Abandonment includes 2 key elements: (1) failing to complete therapy for a disease that could be cured or definitively controlled, and (2) missing all treatment for a sustained time period to an extent that impacts the ability to cure or definitively control the disease. In this Historical Insight paper, we analyze historic and current terminology used to describe treatment abandonment in patients and provide a framework to distinguish it from nonadherence and loss to follow-up.

Original languageEnglish (US)
Pages (from-to)252-256
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume37
Issue number4
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Refusal to Treat
Treatment Failure
Terminology
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Defining and Distinguishing Treatment Abandonment in Patients with Cancer. / Weaver, Meaghann S.; Howard, Scott; Lam, Catherine G.

In: Journal of Pediatric Hematology/Oncology, Vol. 37, No. 4, 01.12.2015, p. 252-256.

Research output: Contribution to journalReview article

@article{6d5f44f20f6a426cbc3ac901c6d09236,
title = "Defining and Distinguishing Treatment Abandonment in Patients with Cancer",
abstract = "Cancer management requires accurate identification of the causes of treatment failure followed by cause-specific interventions. One cause of treatment failure that has received too little attention is abandonment of treatment. Abandonment includes 2 key elements: (1) failing to complete therapy for a disease that could be cured or definitively controlled, and (2) missing all treatment for a sustained time period to an extent that impacts the ability to cure or definitively control the disease. In this Historical Insight paper, we analyze historic and current terminology used to describe treatment abandonment in patients and provide a framework to distinguish it from nonadherence and loss to follow-up.",
author = "Weaver, {Meaghann S.} and Scott Howard and Lam, {Catherine G.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1097/MPH.0000000000000319",
language = "English (US)",
volume = "37",
pages = "252--256",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Defining and Distinguishing Treatment Abandonment in Patients with Cancer

AU - Weaver, Meaghann S.

AU - Howard, Scott

AU - Lam, Catherine G.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Cancer management requires accurate identification of the causes of treatment failure followed by cause-specific interventions. One cause of treatment failure that has received too little attention is abandonment of treatment. Abandonment includes 2 key elements: (1) failing to complete therapy for a disease that could be cured or definitively controlled, and (2) missing all treatment for a sustained time period to an extent that impacts the ability to cure or definitively control the disease. In this Historical Insight paper, we analyze historic and current terminology used to describe treatment abandonment in patients and provide a framework to distinguish it from nonadherence and loss to follow-up.

AB - Cancer management requires accurate identification of the causes of treatment failure followed by cause-specific interventions. One cause of treatment failure that has received too little attention is abandonment of treatment. Abandonment includes 2 key elements: (1) failing to complete therapy for a disease that could be cured or definitively controlled, and (2) missing all treatment for a sustained time period to an extent that impacts the ability to cure or definitively control the disease. In this Historical Insight paper, we analyze historic and current terminology used to describe treatment abandonment in patients and provide a framework to distinguish it from nonadherence and loss to follow-up.

UR - http://www.scopus.com/inward/record.url?scp=84937965236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937965236&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000319

DO - 10.1097/MPH.0000000000000319

M3 - Review article

VL - 37

SP - 252

EP - 256

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 4

ER -